Physiological and Pharmaceutical Study of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.48047/zfwc2v85Keywords:
Cardiovascular disease, Diabetes type 2, Atherosclerotic, Heart disease medications, Drug interactionAbstract
Drug interactions have been studied by different group of researchers, in which they have used a
number of living organisms like humans and animals to reduce or inhibit risk of side effect of drug
disease interaction and enhance action of drugs.
The present study was aimed to investigate the link of cardiovascular disease (CVD) including
atherosclerotic CVD (AsCVD), into patients with type 2 diabetes (T2D) that use sodium-glucose
co-transporter-2 inhibitors(SGLT2is) or glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as
well as to provide more information about the incidence of CVD in T2D patients. The current study
included 422 patients with T2D have diagnosed in Erbil, Kurdistan, Iraq, during their attended to
secondary care facilities. T2D patients were with the median age 66 years and median diabetes
duration 13.3 years. Our results observed that the percentage of AsCVD was 27.2% of all cases of
CVD. The coronary heart disease recorded the highest percentage (20.8%) followed by carotid
artery disease (12.1%).
Downloads
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
